Sector: Healthcare
findl.com provides a comprehensive suite of standardized financial statement data and an assortment of calculated metrics sourced directly from SEC filings, and meticulously cleansed and verified, ensuring reliability. To get the complete financial statement history in quarterly and annual resolution for PFE, sign up here.
Income Statement
Revenue
$58.5bn
Gross Profit
$33.5bn
Earning before Tax
$1.0bn
Net Income
$2.1bn
Net Income Common Shareholders
$2.1bn
EPS
0.38
Balance Sheet
Cash
$2.9bn
Debt
$71.9bn
Assets
$226.5bn
Liabilities
$137.2bn
Equity
$89.0bn
Enterprise Value
$223.0bn
Cash Flow Statement
Net Cash from Operations
$8.7bn
Net Cash from Investing
$-32.3bn
Net Cash from Financing
$26.1bn
Net Cash Flow
$2.4bn
Free Cash Flow
$4.8bn
Free Cash Flow per Share
$0.85
Metrics
Price to Equity
76.72
Price to Equity (Damodaran)
75.76
Price to Book
1.83
Net Margin
0.04
Return on Equity
0.02
Return on Sales
0.02
Get immediate access to 5-years of reference grade data for PFE for free.
Sign upPfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women''s health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; Abrocitinib, under CIBINQO; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc., as well as strategic partnership with CSPC Pharmaceutical Group Limited to launch a local brand of the COVID-19 oral therapeutic treatment Nirmatrelvir/Ritonavir in China, and a collaboration with Carrick Therapeutics Limited. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Company Info
Industry
Drug Manufacturers - General
Employees
Address
66 Hudson Boulevard East
New York, NY 10001-2192
United States
Phone
212 733 2323
Website
Last Updated
2024-02-19
Available Data
Standardized Financial Statements
EOD Price History
Corporate Actions
Institutional Holdings
Insider Transactions
Copyright © findl 2024. All rights reserved.